alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 65, Number 204 (Friday, October 20, 2000)]
[Notices]
[Page 63083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-26963]



[[Page 63083]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel.
    Date: October 18, 2000.
    Time: 2:00 pm to 3:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: 6100 Executive Blvd., DSR Conf. Rm., Rockville, MD 20852 
(Telephone Conference Call).
    Contact Person: Jon M. Ranhand, PhD, Scientist Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, NIH, 6100 Executive Blvd., Room 
5E03, Bethesda, MD 20892, (301) 435-6884.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.209, 
Contraception and Infertility Loan Repayment Program; 93.864, 
Population Research 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research, National 
Institutes of Health, HHS)


    Dated: October 13, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-26963 Filed 10-19-00; 8:45 am]
BILLING CODE 4140-01-M
800 Independence Ave., S.W.

Washington, DC 20591

AFS-12-029-P

November 7, 2012

Mr. Matt Scribner

Vice President of Operations

Inogen, Inc.

326 Bollay Drive

Goleta, CA 93117

Dear Mr. Scribner:

In your October 12, 2011, letter, you petitioned the Federal Aviation Administration 

(FAA) to amend Special Federal Aviation Regulation 106, Section 2 and Section 3(a) of 

Title 14, Code of Federal Regulations (14 CFR). This amendment would include the 

Inogen, Inc., One G3 Portable Oxygen Concentrator (POC) as an approved POC for on

board aircraft.

The FAA amended SFAR 106 on October 16, 2012 (77 FR 63217) to add the following

POC devices that may be carried on and used by a passenger on board an aircraft: 

• AirSep Focus

• AirSep Freestyle 5

• Inogen One G3

• Inova Labs LifeChoice Activox

• Respironics Simply Go

• Precision Medical EasyPulse

• SeQual SAROS

Therefore, we will take no further action on this petition and Docket No. FAA-2011-1138

is being closed.

Sincerely,

/s/

Ida M. Klepper

Manager, Airmen and 

Airspace Rules Division

Enclosure
EXHIBIT 11.1

                    HORIZON OFFSHORE, INC. AND SUBSIDIARIES
                 STATEMENTS REGARDING COMPUTATION OF NET INCOME
                                (LOSS) PER SHARE
                (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

<TABLE>
<CAPTION>
                                                                             INCEPTION
                                                                           (DECEMBER 20,
                                         YEAR ENDED       YEAR ENDED       1995) THROUGH
                                        DECEMBER 31,     DECEMBER 31,      DECEMBER 31,
                                            1998             1997              1996
                                        -------------    -------------    ---------------
<S>                                     <C>              <C>              <C>
Net income (loss)....................    $     12,460     $      2,276      $    (9,580)
                                        =============    =============    ===============
Weighted average shares
  outstanding........................      18,114,393       11,256,373       11,000,000
Dilutive effect of shares issued
  pursuant to warrant exercised
  during 1997........................              --        2,520,834        2,750,000
                                        -------------    -------------    ---------------
Shares used in computing net income
  (loss) per share...................      18,114,393       13,777,207       13,750,000
                                        -------------    -------------    ---------------
Net income (loss) per share..........    $       0.69     $       0.17      $     (0.70)
                                        =============    =============    ===============
</TABLE>
Exhibit 32.B
 
 
 
 
 CERTIFICATION PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO SECTION 906
 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 In connection with the Quarterly Report on Form 10-Q for the period ending March 31, 2011, of Tennessee Gas Pipeline Company (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John R. Sult, Executive Vice President and Chief Financial Officer, certify (i) that the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (ii) that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 /s/ John R. SultJohn R. SultExecutive Vice President and Chief Financial Officer(Principal Financial Officer)Tennessee Gas Pipeline CompanyMay 6, 2011
  
 
 
 
 
 
 
 
 
 
 A signed original of this written statement required by Section 906 has been provided to Tennessee Gas Pipeline Company and will be retained by Tennessee Gas Pipeline Company and furnished to the Securities and Exchange Commission or its staff upon request.
1

ONE BLOOD, INC./FCCI 

INSURANCE GROUP,

Appellants,

v.

ONE BLOOD, INC./ZENITH 

INSURANCE COMPANY

Appellees.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D16-4063

_____________________________/

Opinion filed April 19, 2017.

An appeal from an order of Judge of Compensation Claims.

Wilbur W. Anderson, Judge.

Date of Accident: March 13, 2012.

Thomas G. Portuallo of Eraclides, Gelman, Hall, Indek, Goodman, Waters & 

Traverso, Jacksonville, for Appellants.

William H. Rogner, Winter Park, for Appellees.

PER CURIAM.

AFFIRMED.

ROBERTS, C.J., MAKAR, JAY, JJ., CONCUR.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           8,603
<SECURITIES>                                         0
<RECEIVABLES>                                    5,504
<ALLOWANCES>                                       358
<INVENTORY>                                          0
<CURRENT-ASSETS>                                14,800
<PP&E>                                         162,662
<DEPRECIATION>                                (28,388)
<TOTAL-ASSETS>                                 156,451
<CURRENT-LIABILITIES>                           16,870
<BONDS>                                        131,630
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            27
<OTHER-SE>                                    (10,467)
<TOTAL-LIABILITY-AND-EQUITY>                   156,451
<SALES>                                         31,962
<TOTAL-REVENUES>                                32,316
<CGS>                                           13,349
<TOTAL-COSTS>                                   30,579
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                    30
<INTEREST-EXPENSE>                              13,197
<INCOME-PRETAX>                               (11,797)
<INCOME-TAX>                                   (4,200)
<INCOME-CONTINUING>                            (7,597)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  1,140
<CHANGES>                                            0
<NET-INCOME>                                   (6,457)
<EPS-PRIMARY>                                   (2.37)
<EPS-DILUTED>                                   (2.37)
        

</TABLE>
#### HARRELL v. STATE.

No. 24279.

Court of Criminal Appeals of Texas.

March 16, 1949.

No appearance for appellant.

Ernest S. Goens, State’s Atty., of Austin, for the State.

KRUEGER, Judge.

The offense is an assault with intent to murder. The punishment assessed is confinement in the state penitentiary for a term of two years.

The record in this case reflects an indefinite verdict, and the court in pronouncing sentence upon appellant failed to give effect to the indeterminate sentence law, Vernon’s Ann.C.C.P. Art. 775. The indictment charged appellant with an assault to murder with malice. The court instructed the jury on an assault to murder with and without malice. The jury returned the following verdict: “We the Jury find the defendant guilty and access his punishment (2) two years in the state penitentiary. Signed Sam Cook, foreman.”

Looking to the verdict as written, it is impossible to determine whether the jury found him guilty of an assault with an intent to murder with or without malice. The punishment prescribed by law for an assault with intent to murder with malice is by confinement in the penitentiary for a term of not less than two nor more than fifteen years, while the punishment for an assault to murder without malice is not less than one nor more than three years. The trial court sentenced him to two years confinement in the state penitentiary without giving effect to the indeterminate sentence law. In the absence of a finding by the jury of whether he was guilty of an assault to murder with or without malice, the trial court was not in a position to make application of the indeterminate sentence, nor is this court in a position to do so. See Johnson v. State, 137 Tex.Cr.R. 82, 128 S.W.2d 384; Jordan v. State, 140 Tex.Cr.R. 238, 144 S.W.2d 274; and Brooks v. State, 147 Tex.Cr.R. 98, 178 S.W.2d 865.

Appellant is entitled to the benefit of the indeterminate sentence. This was not accorded to him which requires a reversal of this case.

It will not be necessary to here discuss appellant’s bills of exceptions. However, in the event of another trial, all evidence relative to any offense his brother may have committed some years prior to the offense alleged to have been committed by appellant and anything appellant may *467have done to another person which has no connection with the offense for which he was on trial should not be admitted in evidence.

For the error herein pointed out, the judgment of the trial court is reversed and the cause is remanded.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the Judges of the Court of Criminal Appeals and approved by the Court.
Case 5:20-cv-00746-JKP-HJB Document 75 Filed 05/31/22 Page 1 of 2
Case 5:20-cv-00746-JKP-HJB Document 75 Filed 05/31/22 Page 2 of 2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. RP00-506-002]

Take notice that on October 6, 2000, Northwest Pipeline Corporation (Northwest) submitted supplemental information in support of its partial capacity turnback proposal in this proceeding.

Northwest states that the purpose of this filing is to comply with the Commission's Order, dated September 22, 2000, which directed Northwest to file such supplemental information.

Northwest states that it has served a copy of this compliance filing upon each person designated on the official service list compiled by the Secretary in this proceeding.

Any person desiring to protest said filing should file a protest with the Federal Energy Commission, 888 First Street, NE, Washington, DC 20426, in accordance with section 385.211 of the Commission's Rules and Regulations. All such protests must be filed on or before October 20, 2000. Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceedings. Copies of this filing are on file with the Commission and are available for public inspection in the Public Reference Room. This filing may be viewed on the web at http://www.ferc.fed.us/​online.rims.htm (call 202-208-2222 for assistance).

Linwood A. Watson, Jr.,

Acting Secretary.

[FR Doc. 00-26833  Filed 10-18-00; 8:45 am]

BILLING CODE 6717-01-M
Exhibit 11
                          THE STRIDE RITE CORPORATION

                       COMPUTATION OF PER SHARE EARNINGS

                      (In Thousands except Per Share Data)

<TABLE>

<CAPTION>
                             Three Months Ended          Nine Months Ended
                         Aug.30,1996  Sept. 1,1995  Aug.30,1996  Sept. 1,1995


Net income applicable
<S>                         <C>           <C>         <C>           <C>    
  to common shares          $ 3,193       $ 3,487     $7,583        $12,463
Calculation of shares:

   Weighted average num-
     ber of common
     shares outstanding      49,607        49,441     49,581         49,506

   Common shares attri-
     butable to assumed
     exercise of dilu-
     tive stock options
     and stock purchase
     rights using the
     treasury stock
     method                     224           300        246            310

Average common shares
  and common equiva-
  lents outstanding
  during the
  period                     49,831        49,741     49,827         49,816

Net income per common
   share                       $.06          $.07       $.15           $.25

</TABLE>







                                            15


<PAGE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                        National Cancer Institute Special Emphasis Panel Lung Image Data Base Resource for Imaging Research.                    

*Date:*                        November 9, 2000.                    

*Time:*                        8:00 AM to 4:00 PM.                    

*Agenda:*                        To review and evaluate grant applications.                    

*Place:*                        Ramada Inn Rockville, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                        Gerald G. Lovinger, PHD, Scientific Review Administrator, Grants Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8070, Rockville, MD 20892-7405, 301/496-7987.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: October 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-26859  Filed 10-18-00; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 32.1

Certification of Chief Executive Officer of Sunoco, Inc.

Pursuant to 18
U.S.C. Section 1350

In connection with this Quarterly Report on Form 10-Q of Sunoco, Inc. for the quarter ended
June 30, 2011, I, Lynn L. Elsenhans, Chairman, Chief Executive Officer and President of Sunoco, Inc., certify pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report on Form 10-Q for the quarter ended June 30, 2011 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the periodic report fairly presents, in all
material respects, the financial condition and results of operations of Sunoco, Inc.



|                     |  |  |  |  |  |                                                
|-------------------- |  |  |  |  |  | -----------------------------------------------
|Date: August 4, 2011 |  |  |  |  |  | /s/ Lynn L. Elsenhans                          
|                     |  |  |  |  |  | Lynn L. Elsenhans                              
|                     |  |  |  |  |  | Chairman, Chief Executive
Officer and President
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED AU GUST 3, 2017

NO. 03

- 17

- 00046

- CV

Matthew Bialaszewski, Appellant

v.

Amanda Bialaszewski, Appellee

APPEAL FROM THE 353RD DISTRICT COURT OF TRAVIS COUNTY

BEFORE JUSTICES PURYEAR , PEMBERTON, AND GOO DWIN
REVERSED AND RENDERED

-- OPINION BY JUSTICE PURYEAR

This is an appeal from the tr i a l court ’s order granting appellee’s petition for bill of review,

signed on November 10, 2016. Having reviewed the record and the parties’ arguments, the

Court holds that there was reversible error in the order . Therefore, the Court reverses the trial

court’s order and arrearage finding and renders judgment denying appellee’ s petition for bill of

review. The order challenged by appellee remains in full force and effect. A ppellee shall pay all

costs relating to this appeal, both in this Court and the court below.
#### Gallagher et al., Appellants, *v.*City of Bexley et al., Appellees.

(No. 27595

Decided November 29, 1939.)

*Messrs. Coughlin, Ogier & Lloyd,*for appellants.

*Mr. Harley E. Peters,*for appellees.

It is ordered and adjudged that said appeal as of right be, and the same hereby is, dismissed for the reason no debatable constitutional question is involved in said cause.

*Appeal dismissed.*

Weygandt, C. J., Day, Zimmerman, Williams, Myers, Matthias and Hart, JJ., concur.
I 

113TH CONGRESS 

1ST SESSION H. R. 2976 

To amend the Violent Crime Control and Law Enforcement Act of 1994 

to reauthorize the Missing Alzheimer’s Disease Patient Alert Program. 

IN THE HOUSE OF REPRESENTATIVES 

AUGUST 1, 2013 

Ms. WATERS (for herself, Mr. SMITH of New Jersey, Mr. VAN HOLLEN, Mr. 

GRIJALVA, Ms. BORDALLO, Mrs. CHRISTENSEN, Mr. LYNCH, Ms. LORETTA SANCHEZ of California, Ms. LINDA T. SA ́NCHEZ of California, Ms. 

JACKSON LEE, Ms. SEWELL of Alabama, Mr. HASTINGS of Florida, Ms. 

WILSON of Florida, Mr. PAYNE, Ms. NORTON, Ms. BROWN of Florida, 

Mr. CARSON of Indiana, Mr. CONNOLLY, Mr. RANGEL, Mr. FARR, Ms. 

LEE of California, Mr. HINOJOSA, Ms. MCCOLLUM, Mr. POLIS, Mr. 

DAVID SCOTT of Georgia, Ms. CLARKE, Mr. RYAN of Ohio, Ms. ROSLEHTINEN, Mr. KEATING, and Ms. SCHAKOWSKY) introduced the following bill; which was referred to the Committee on the Judiciary 

A BILL 

To amend the Violent Crime Control and Law Enforcement 

Act of 1994 to reauthorize the Missing Alzheimer’s Disease Patient Alert Program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Missing Alzheimer’s 

5 Disease Patient Alert Program Reauthorization Act of 

6 2013’’. 


jbell on DSK7SPTVN1PROD with BILLS
2 

•HR 2976 IH

1 SEC. 2. REAUTHORIZATION OF THE MISSING ALZHEIMER’S 

2 DISEASE PATIENT ALERT PROGRAM. 

3 Section 240001 of the Violent Crime Control and 

4 Law Enforcement Act of 1994 (42 U.S.C. 14181) is 

5 amended— 

6 (1) by amending subsection (a) to read as fol7 lows: 

8 ‘‘(a) GRANT.—Subject to the availability of appro9 priations to carry out this section, the Attorney General, 

10 through the Bureau of Justice Assistance and in consulta11 tion with the Secretary of Health and Human Services, 

12 shall award competitive grants to nonprofit organizations 

13 to assist such organizations in paying for the costs of plan14 ning, designing, establishing, and operating locally based, 

15 proactive programs to protect and locate missing patients 

16 with Alzheimer’s disease and related dementias.’’; 

17 (2) in subsection (b), by inserting ‘‘competitive’’ 

18 after ‘‘to receive a’’; 

19 (3) by amending subsection (c) to read as fol20 lows: 

21 ‘‘(c) PREFERENCE.—In awarding grants under sub22 section (a), the Attorney General shall give preference to 

23 national nonprofit organizations that have experience 

24 working with patients, and families of patients, with Alz25 heimer’s disease and related dementias.’’; and 


jbell on DSK7SPTVN1PROD with BILLS
3 

•HR 2976 IH

1 (4) by amending subsection (d) to read as fol2 lows: 

3 ‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated to carry out this section 

5 $5,000,000 for each of the fiscal years 2014 through 

6 2018.’’. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS